Share

Networks

Clinical Studies (2)

  • Pinargote-Celorio : Study aims to assess the effectiveness of early antiviral treatment in reducing hospitalizations in a real-world cohort of severely immunocompromised COVID-19 outpatients
  • BLOC : Study aims to investigate the efficacy, pharmacodynamics and safety of BC 007 in improving long COVID symptoms by neutralising functional autoantibodies targeting G-protein

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Remdesivir
  • Nirmatrelvir/Ritonavir
  • Sotrovimab
  • BC 007

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to